Exodus Point Capital Management, LP Dr Reddys Laboratories LTD Transaction History

Exodus Point Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$49.9 - $57.32 $74,001 - $85,005	1,483 Added 38.03%	5,383 $282,000
Q2 2022 Aug 19, 2022	BUY	$49.62 - $58.13 $8,435 - $9,882	170 Added 4.56%	3,900 $216,000
Q1 2022 May 13, 2022	BUY	$48.27 - $65.25 $180,047 - $243,382	3,730 New	3,730 $208,000
Q1 2020 May 15, 2020	SELL	$34.75 - $45.85 $426,069 - $562,166	-12,261 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$36.66 - $41.78 $449,488 - $512,264	12,261 New	12,261 $498,000

265

107M

71K

22.5K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.21B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.